LD538 amends prescription-drug labeling rules to allow the prescriber’s name to be removed specifically for mifepristone, misoprostol, and their generic equivalents. At the prescriber’s request, the pharmacy label may list the name of the prescriber’s healthcare facility instead of the individual practitioner, while all other standard labeling requirements remain in place.
The Maine State House of Representatives passed LD538 on May 20, 2025 by a vote of 75 to 71. We have assigned pluses to the nays because this bill conceals the identities of prescribers who dispense abortion-inducing drugs, shielding them from accountability and further normalizing the destruction of innocent human life. Mifepristone and misoprostol are used to end the life of a preborn child, and removing prescriber transparency only enables an already unrestrained abortion regime. The care of human life—not its destruction—is the highest duty of government. Yet LD538 treats abortion as routine “healthcare,” disregarding the God-given, unalienable right to life affirmed in the Declaration of Independence and secured by the Fifth and 14th Amendments. Government has no authority to hide those involved in taking human life; rather, it must protect that life at every stage.